home register
search sitemap legal statement
At your Service
Print Page
New LightCycler® Adapt Software allows automated testing of K-RAS status of colorectal cancer patients
The TheraScreen®: K-RAS Mutation Kit (CE-IVD) - manufactured by DxS and exclusively distributed by Roche Diagnostics - has received CE-IVD mark certification for use on Roche's LightCycler® 480 Instrument II together with LightCycler® Adapt Software. The software allows automated processing of K-RAS mutation status tests for colorectal cancer patients.

The TheraScreen®: K-RAS Mutation Test helps doctors to identify a patient's K-RAS mutation status and response to anti-EGFR therapies for colorectal cancer.
LightCycler® Adapt Software v1.1 for TheraScreen®: K-RAS Mutation Kit is a specialised software package for use with the LightCycler® 480 Instrument II which provides automated data processing, avoiding manual interpretation and human error. The software generates data that is compatible with both LIMS (Laboratory Information Management System) and PMS (Patient Management System), and produces the results in a read-only format, ensuring patient's results are secure. In addition, the software has a built-in warning system which generates a troubleshooting message if an assay has not been run correctly.

Please read the product information flyer for further details.